| UniProt ID | CSTF3_HUMAN | |
|---|---|---|
| UniProt AC | Q12996 | |
| Protein Name | Cleavage stimulation factor subunit 3 | |
| Gene Name | CSTF3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 717 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | One of the multiple factors required for polyadenylation and 3'-end cleavage of mammalian pre-mRNAs.. | |
| Protein Sequence | MSGDGATEQAAEYVPEKVKKAEKKLEENPYDLDAWSILIREAQNQPIDKARKTYERLVAQFPSSGRFWKLYIEAEIKAKNYDKVEKLFQRCLMKVLHIDLWKCYLSYVRETKGKLPSYKEKMAQAYDFALDKIGMEIMSYQIWVDYINFLKGVEAVGSYAENQRITAVRRVYQRGCVNPMINIEQLWRDYNKYEEGINIHLAKKMIEDRSRDYMNARRVAKEYETVMKGLDRNAPSVPPQNTPQEAQQVDMWKKYIQWEKSNPLRTEDQTLITKRVMFAYEQCLLVLGHHPDIWYEAAQYLEQSSKLLAEKGDMNNAKLFSDEAANIYERAISTLLKKNMLLYFAYADYEESRMKYEKVHSIYNRLLAIEDIDPTLVYIQYMKFARRAEGIKSGRMIFKKAREDTRTRHHVYVTAALMEYYCSKDKSVAFKIFELGLKKYGDIPEYVLAYIDYLSHLNEDNNTRVLFERVLTSGSLPPEKSGEIWARFLAFESNIGDLASILKVEKRRFTAFKEEYEGKETALLVDRYKFMDLYPCSASELKALGYKDVSRAKLAAIIPDPVVAPSIVPVLKDEVDRKPEYPKPDTQQMIPFQPRHLAPPGLHPVPGGVFPVPPAAVVLMKLLPPPICFQGPFVQVDELMEIFRRCKIPNTVEEAVRIITGGAPELAVEGNGPVESNAVLTKAVKRPNEDSDEDEEKGAVVPPVHDIYRARQQKRIR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSGDGATEQ ------CCCCCHHHH | 45.66 | 25849741 | |
| 2 | Acetylation | ------MSGDGATEQ ------CCCCCHHHH | 45.66 | 22223895 | |
| 7 | Phosphorylation | -MSGDGATEQAAEYV -CCCCCHHHHHHHHC | 33.87 | 30108239 | |
| 13 | Nitration | ATEQAAEYVPEKVKK HHHHHHHHCHHHHHH | 19.31 | - | |
| 17 | Ubiquitination | AAEYVPEKVKKAEKK HHHHCHHHHHHHHHH | 53.97 | - | |
| 20 | Ubiquitination | YVPEKVKKAEKKLEE HCHHHHHHHHHHHHH | 65.84 | - | |
| 49 | 2-Hydroxyisobutyrylation | AQNQPIDKARKTYER HHCCCCHHHHHHHHH | 51.30 | - | |
| 49 | Ubiquitination | AQNQPIDKARKTYER HHCCCCHHHHHHHHH | 51.30 | 24816145 | |
| 49 | Acetylation | AQNQPIDKARKTYER HHCCCCHHHHHHHHH | 51.30 | 26051181 | |
| 54 | Phosphorylation | IDKARKTYERLVAQF CHHHHHHHHHHHHHC | 11.33 | 24719451 | |
| 63 | Phosphorylation | RLVAQFPSSGRFWKL HHHHHCCCCCCCEEE | 46.87 | 24719451 | |
| 64 | Phosphorylation | LVAQFPSSGRFWKLY HHHHCCCCCCCEEEE | 33.94 | 24719451 | |
| 86 | Ubiquitination | KNYDKVEKLFQRCLM CCHHHHHHHHHHHHH | 58.55 | 29967540 | |
| 86 | Acetylation | KNYDKVEKLFQRCLM CCHHHHHHHHHHHHH | 58.55 | 27452117 | |
| 94 | Ubiquitination | LFQRCLMKVLHIDLW HHHHHHHHHHCHHHH | 28.79 | 23000965 | |
| 104 | Phosphorylation | HIDLWKCYLSYVRET CHHHHHHHHHHHHHC | 8.58 | - | |
| 107 | Phosphorylation | LWKCYLSYVRETKGK HHHHHHHHHHHCCCC | 10.84 | - | |
| 114 | Acetylation | YVRETKGKLPSYKEK HHHHCCCCCCCHHHH | 59.80 | 23749302 | |
| 121 | Ubiquitination | KLPSYKEKMAQAYDF CCCCHHHHHHHHHHH | 35.07 | 33845483 | |
| 121 | Malonylation | KLPSYKEKMAQAYDF CCCCHHHHHHHHHHH | 35.07 | 30639696 | |
| 126 | Phosphorylation | KEKMAQAYDFALDKI HHHHHHHHHHHHHHH | 10.26 | - | |
| 139 | Phosphorylation | KIGMEIMSYQIWVDY HHCHHHHHHHHHHHH | 21.39 | - | |
| 140 | Phosphorylation | IGMEIMSYQIWVDYI HCHHHHHHHHHHHHH | 6.14 | - | |
| 158 | Phosphorylation | KGVEAVGSYAENQRI HCHHHHHHHHHHCCH | 17.99 | 28152594 | |
| 159 | Phosphorylation | GVEAVGSYAENQRIT CHHHHHHHHHHCCHH | 16.41 | 28152594 | |
| 159 | Nitration | GVEAVGSYAENQRIT CHHHHHHHHHHCCHH | 16.41 | - | |
| 192 | Acetylation | QLWRDYNKYEEGINI HHHHHHHHHHHCCCH | 48.05 | 26051181 | |
| 192 | Ubiquitination | QLWRDYNKYEEGINI HHHHHHHHHHHCCCH | 48.05 | 21890473 | |
| 203 | 2-Hydroxyisobutyrylation | GINIHLAKKMIEDRS CCCHHHHHHHHHHHC | 49.59 | - | |
| 228 | Acetylation | KEYETVMKGLDRNAP HHHHHHHHCCCCCCC | 52.57 | 25953088 | |
| 228 | Ubiquitination | KEYETVMKGLDRNAP HHHHHHHHCCCCCCC | 52.57 | 32015554 | |
| 236 | Phosphorylation | GLDRNAPSVPPQNTP CCCCCCCCCCCCCCC | 44.86 | 29978859 | |
| 242 | Phosphorylation | PSVPPQNTPQEAQQV CCCCCCCCCHHHHHH | 22.54 | 29978859 | |
| 261 | Phosphorylation | KYIQWEKSNPLRTED HHHHHHHCCCCCCCC | 31.97 | 21712546 | |
| 266 | Phosphorylation | EKSNPLRTEDQTLIT HHCCCCCCCCCCHHH | 52.15 | 20068231 | |
| 270 | Phosphorylation | PLRTEDQTLITKRVM CCCCCCCCHHHHHHH | 32.23 | 20068231 | |
| 273 | Phosphorylation | TEDQTLITKRVMFAY CCCCCHHHHHHHHHH | 18.86 | 20068231 | |
| 274 | 2-Hydroxyisobutyrylation | EDQTLITKRVMFAYE CCCCHHHHHHHHHHH | 35.68 | - | |
| 274 | Ubiquitination | EDQTLITKRVMFAYE CCCCHHHHHHHHHHH | 35.68 | 22817900 | |
| 311 | 2-Hydroxyisobutyrylation | SSKLLAEKGDMNNAK HHHHHHHCCCCCCCC | 55.38 | - | |
| 321 | Phosphorylation | MNNAKLFSDEAANIY CCCCCCCCHHHHHHH | 45.00 | - | |
| 328 | Phosphorylation | SDEAANIYERAISTL CHHHHHHHHHHHHHH | 10.12 | 28152594 | |
| 333 | Phosphorylation | NIYERAISTLLKKNM HHHHHHHHHHHHHCC | 16.42 | 23403867 | |
| 334 | Phosphorylation | IYERAISTLLKKNML HHHHHHHHHHHHCCH | 29.96 | 23403867 | |
| 337 | 2-Hydroxyisobutyrylation | RAISTLLKKNMLLYF HHHHHHHHHCCHHHH | 45.26 | - | |
| 355 | Acetylation | DYEESRMKYEKVHSI CHHHHHHHHHHHHHH | 49.50 | 19809697 | |
| 356 | Phosphorylation | YEESRMKYEKVHSIY HHHHHHHHHHHHHHH | 16.19 | 30576142 | |
| 358 | Acetylation | ESRMKYEKVHSIYNR HHHHHHHHHHHHHHH | 42.00 | 19809705 | |
| 361 | Phosphorylation | MKYEKVHSIYNRLLA HHHHHHHHHHHHHHH | 29.74 | 30576142 | |
| 363 | Phosphorylation | YEKVHSIYNRLLAIE HHHHHHHHHHHHHHH | 9.39 | 30576142 | |
| 392 | 2-Hydroxyisobutyrylation | ARRAEGIKSGRMIFK HHHHHCCCCCCEEEH | 58.68 | - | |
| 412 | Phosphorylation | TRTRHHVYVTAALME CCCCCHHHHHHHHHH | 6.42 | 24043423 | |
| 414 | Phosphorylation | TRHHVYVTAALMEYY CCCHHHHHHHHHHHH | 6.63 | 24043423 | |
| 420 | Phosphorylation | VTAALMEYYCSKDKS HHHHHHHHHHCCCCC | 8.87 | 24043423 | |
| 421 | Phosphorylation | TAALMEYYCSKDKSV HHHHHHHHHCCCCCH | 4.12 | 24043423 | |
| 423 | Phosphorylation | ALMEYYCSKDKSVAF HHHHHHHCCCCCHHH | 27.97 | 24043423 | |
| 426 | 2-Hydroxyisobutyrylation | EYYCSKDKSVAFKIF HHHHCCCCCHHHHHH | 51.03 | - | |
| 427 | Phosphorylation | YYCSKDKSVAFKIFE HHHCCCCCHHHHHHH | 28.89 | 23312004 | |
| 431 | Ubiquitination | KDKSVAFKIFELGLK CCCCHHHHHHHCCHH | 36.43 | 33845483 | |
| 431 | Acetylation | KDKSVAFKIFELGLK CCCCHHHHHHHCCHH | 36.43 | 26051181 | |
| 472 | Phosphorylation | VLFERVLTSGSLPPE HEEEEHHHCCCCCCC | 28.34 | 29396449 | |
| 473 | Phosphorylation | LFERVLTSGSLPPEK EEEEHHHCCCCCCCC | 23.40 | 29396449 | |
| 475 | Phosphorylation | ERVLTSGSLPPEKSG EEHHHCCCCCCCCCH | 37.15 | 29396449 | |
| 500 | Phosphorylation | SNIGDLASILKVEKR CCHHHHHHHHHHHHH | 35.43 | 24719451 | |
| 513 | Acetylation | KRRFTAFKEEYEGKE HHHCCCCHHHHCCCC | 47.36 | 26051181 | |
| 513 | 2-Hydroxyisobutyrylation | KRRFTAFKEEYEGKE HHHCCCCHHHHCCCC | 47.36 | - | |
| 519 | 2-Hydroxyisobutyrylation | FKEEYEGKETALLVD CHHHHCCCCEEEEEE | 39.69 | - | |
| 519 | Ubiquitination | FKEEYEGKETALLVD CHHHHCCCCEEEEEE | 39.69 | 33845483 | |
| 529 | Ubiquitination | ALLVDRYKFMDLYPC EEEEECHHCCCCCCC | 34.80 | 29967540 | |
| 529 | Acetylation | ALLVDRYKFMDLYPC EEEEECHHCCCCCCC | 34.80 | 26051181 | |
| 534 | Phosphorylation | RYKFMDLYPCSASEL CHHCCCCCCCCHHHH | 9.64 | 22817900 | |
| 542 | Acetylation | PCSASELKALGYKDV CCCHHHHHHCCCCCC | 37.20 | 7408175 | |
| 546 | Phosphorylation | SELKALGYKDVSRAK HHHHHCCCCCCCHHH | 12.59 | - | |
| 547 | Acetylation | ELKALGYKDVSRAKL HHHHCCCCCCCHHHH | 50.27 | 26051181 | |
| 553 | Ubiquitination | YKDVSRAKLAAIIPD CCCCCHHHHHHHCCC | 37.23 | 33845483 | |
| 566 | Phosphorylation | PDPVVAPSIVPVLKD CCCCCCCHHHHHCCC | 26.87 | - | |
| 651 | Phosphorylation | RRCKIPNTVEEAVRI HHCCCCCCHHHHHHH | 24.76 | 25599653 | |
| 676 | Phosphorylation | EGNGPVESNAVLTKA ECCCCCCCCCCHHHH | 30.26 | 26074081 | |
| 681 | Phosphorylation | VESNAVLTKAVKRPN CCCCCCHHHHHCCCC | 15.45 | 26074081 | |
| 682 | Acetylation | ESNAVLTKAVKRPNE CCCCCHHHHHCCCCC | 47.20 | 23236377 | |
| 682 | Ubiquitination | ESNAVLTKAVKRPNE CCCCCHHHHHCCCCC | 47.20 | 21906983 | |
| 685 | Ubiquitination | AVLTKAVKRPNEDSD CCHHHHHCCCCCCCC | 67.98 | 22817900 | |
| 691 | Phosphorylation | VKRPNEDSDEDEEKG HCCCCCCCCCCHHCC | 36.40 | 29255136 | |
| 708 | Phosphorylation | VPPVHDIYRARQQKR CCCHHHHHHHHHHHH | 12.32 | 24732914 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CSTF3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CSTF3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSTF3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CSTFT_HUMAN | CSTF2T | physical | 22939629 | |
| G3P_HUMAN | GAPDH | physical | 22939629 | |
| CSTF1_HUMAN | CSTF1 | physical | 11459828 | |
| CSTFT_HUMAN | CSTF2T | physical | 26344197 | |
| PABP1_HUMAN | PABPC1 | physical | 26344197 | |
| PABP3_HUMAN | PABPC3 | physical | 26344197 | |
| PAPOB_HUMAN | PAPOLB | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASSSPECTROMETRY. | |